Nephew Plc
Last updated on 2017-08-31T19:05+0300.
About this image
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|
| Names | Lang | Count |
|---|---|---|
| Nephew Plc | EN | 100.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Inc | 12.30% |
| Zimmer Biomet Holdings | 4.17% |
| Five Forces | 3.76% |
| Cardinal Health | 2.95% |
 | Table | 2.95% |
| Stryker Corporation | 2.64% |
| Stryker Corp | 2.44% |
| Boston Scientific | 2.03% |
| Saudi | 2.03% |
| Becton Dickinson | 2.03% |
| British | 1.93% |
| Supreme Court | 1.63% |
| Laura Wood | 1.52% |
| Conmed Corporation | 1.42% |
| Patent Trial and Appeal Board | 1.42% |
| Karl Storz | 1.22% |
| Pvt Ltd | 1.22% |
| Solutions | 1.22% |
| Strategy | 1.22% |
| John Roberts | 1.22% |
| Of The | 1.12% |
| Paul Hartmann | 1.02% |
| World Health Organization | 1.02% |
| Abbott Laboratories | 1.02% |
| Siemens | 1.02% |
| S government | 1.02% |
| 1.02% | |
| Record | 0.91% |
| Pfizer Inc | 0.91% |
| Alphabet Inc | 0.91% |
| Type | Entity Name | Score |
|---|---|---|
| Zimmer Biomet Holdings | 0.0409 |
| Five Forces | 0.0348 |
| Cardinal Health | 0.0289 |
| Stryker Corporation | 0.0247 |
| Table | 0.0238 |
| Stryker Corp | 0.0235 |
| Roland Diggelmann | 0.0224 |
| Becton Dickinson | 0.0202 |
| Boston Scientific | 0.0199 |
| Inc | 0.0162 |
| Conmed Corporation | 0.0138 |
| Laura Wood | 0.0124 |
| Karl Storz | 0.0119 |
| Pvt Ltd | 0.0109 |
| Patent Trial and Appeal Board | 0.0102 |
| Siemens | 0.0099 |
| Paul Hartmann | 0.0098 |
| Abbott Laboratories | 0.0094 |
| John Roberts | 0.0086 |
| Apple Computer | 0.0081 |
| Olympus Corporation | 0.0081 |
| Alphabet Inc | 0.0078 |
| Solutions | 0.0075 |
| Key Findings | 0.0075 |
| Strategy | 0.0074 |
| Product Development | 0.0073 |
| Market Development | 0.0073 |
| Record | 0.0062 |
| GlaxoSmithKline Plc | 0.006 |
| Global Inc | 0.0059 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Wednesday, February 8, 2023
1:27:00 AM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 